1 Tenofovir Disoproxil Fumarate Market Overview 1.1 Tenofovir Disoproxil Fumarate Product Overview 1.2 Tenofovir Disoproxil Fumarate Market Segment by Type 1.2.1 30 Pcs/Box 1.2.2 10 Pcs/Box 1.3 Global Tenofovir Disoproxil Fumarate Market Size by Type 1.3.1 Global Tenofovir Disoproxil Fumarate Market Size Overview by Type (2016-2027) 1.3.2 Global Tenofovir Disoproxil Fumarate Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Tenofovir Disoproxil Fumarate Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Tenofovir Disoproxil Fumarate Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2016-2021) 1.4.2 Europe Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Tenofovir Disoproxil Fumarate Sales Breakdown by Type (2016-2021) 2 Global Tenofovir Disoproxil Fumarate Market Competition by Company 2.1 Global Top Players by Tenofovir Disoproxil Fumarate Sales (2016-2021) 2.2 Global Top Players by Tenofovir Disoproxil Fumarate Revenue (2016-2021) 2.3 Global Top Players Tenofovir Disoproxil Fumarate Price (2016-2021) 2.4 Global Top Manufacturers Tenofovir Disoproxil Fumarate Manufacturing Base Distribution, Sales Area, Product Type 2.5 Tenofovir Disoproxil Fumarate Market Competitive Situation and Trends 2.5.1 Tenofovir Disoproxil Fumarate Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Tenofovir Disoproxil Fumarate Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate as of 2020) 2.7 Date of Key Manufacturers Enter into Tenofovir Disoproxil Fumarate Market 2.8 Key Manufacturers Tenofovir Disoproxil Fumarate Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Tenofovir Disoproxil Fumarate Status and Outlook by Region 3.1 Global Tenofovir Disoproxil Fumarate Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Tenofovir Disoproxil Fumarate Historic Market Size by Region 3.2.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2016-2021) 3.2.2 Global Tenofovir Disoproxil Fumarate Sales in Value by Region (2016-2021) 3.2.3 Global Tenofovir Disoproxil Fumarate Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Region 3.3.1 Global Tenofovir Disoproxil Fumarate Sales in Volume by Region (2022-2027) 3.3.2 Global Tenofovir Disoproxil Fumarate Sales in Value by Region (2022-2027) 3.3.3 Global Tenofovir Disoproxil Fumarate Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Tenofovir Disoproxil Fumarate by Application 4.1 Tenofovir Disoproxil Fumarate Market Segment by Application 4.1.1 HIV-1 Infection 4.1.2 Chronic Hepatitis 4.1.3 Other 4.2 Global Tenofovir Disoproxil Fumarate Market Size by Application 4.2.1 Global Tenofovir Disoproxil Fumarate Market Size Overview by Application (2016-2027) 4.2.2 Global Tenofovir Disoproxil Fumarate Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Tenofovir Disoproxil Fumarate Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Tenofovir Disoproxil Fumarate Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Tenofovir Disoproxil Fumarate Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Tenofovir Disoproxil Fumarate Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2016-2021) 4.3.2 Europe Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Tenofovir Disoproxil Fumarate Sales Breakdown by Application (2016-2021) 5 North America Tenofovir Disoproxil Fumarate by Country 5.1 North America Tenofovir Disoproxil Fumarate Historic Market Size by Country 5.1.1 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2021) 5.1.2 North America Tenofovir Disoproxil Fumarate Sales in Value by Country (2016-2021) 5.2 North America Tenofovir Disoproxil Fumarate Forecasted Market Size by Country 5.2.1 North America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2022-2027) 5.2.2 North America Tenofovir Disoproxil Fumarate Sales in Value by Country (2022-2027) 6 Europe Tenofovir Disoproxil Fumarate by Country 6.1 Europe Tenofovir Disoproxil Fumarate Historic Market Size by Country 6.1.1 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2021) 6.1.2 Europe Tenofovir Disoproxil Fumarate Sales in Value by Country (2016-2021) 6.2 Europe Tenofovir Disoproxil Fumarate Forecasted Market Size by Country 6.2.1 Europe Tenofovir Disoproxil Fumarate Sales in Volume by Country (2022-2027) 6.2.2 Europe Tenofovir Disoproxil Fumarate Sales in Value by Country (2022-2027) 7 Asia-Pacific Tenofovir Disoproxil Fumarate by Region 7.1 Asia-Pacific Tenofovir Disoproxil Fumarate Historic Market Size by Region 7.1.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Tenofovir Disoproxil Fumarate Forecasted Market Size by Region 7.2.1 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Tenofovir Disoproxil Fumarate Sales in Value by Region (2022-2027) 8 Latin America Tenofovir Disoproxil Fumarate by Country 8.1 Latin America Tenofovir Disoproxil Fumarate Historic Market Size by Country 8.1.1 Latin America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2021) 8.1.2 Latin America Tenofovir Disoproxil Fumarate Sales in Value by Country (2016-2021) 8.2 Latin America Tenofovir Disoproxil Fumarate Forecasted Market Size by Country 8.2.1 Latin America Tenofovir Disoproxil Fumarate Sales in Volume by Country (2022-2027) 8.2.2 Latin America Tenofovir Disoproxil Fumarate Sales in Value by Country (2022-2027) 9 Middle East and Africa Tenofovir Disoproxil Fumarate by Country 9.1 Middle East and Africa Tenofovir Disoproxil Fumarate Historic Market Size by Country 9.1.1 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Tenofovir Disoproxil Fumarate Forecasted Market Size by Country 9.2.1 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Tenofovir Disoproxil Fumarate Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Tenofovir Disoproxil Fumarate Business 10.1 Glaxo SmithKline 10.1.1 Glaxo SmithKline Corporation Information 10.1.2 Glaxo SmithKline Introduction and Business Overview 10.1.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Products Offered 10.1.5 Glaxo SmithKline Recent Development 10.2 Gilead PHARMACARE 10.2.1 Gilead PHARMACARE Corporation Information 10.2.2 Gilead PHARMACARE Introduction and Business Overview 10.2.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Products Offered 10.2.5 Gilead PHARMACARE Recent Development 10.3 Chengdu Brilliant Pharmaceutical 10.3.1 Chengdu Brilliant Pharmaceutical Corporation Information 10.3.2 Chengdu Brilliant Pharmaceutical Introduction and Business Overview 10.3.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered 10.3.5 Chengdu Brilliant Pharmaceutical Recent Development 10.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical 10.4.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Corporation Information 10.4.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Introduction and Business Overview 10.4.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.4.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered 10.4.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development 10.5 Anhui Biochem Pharmaceutical 10.5.1 Anhui Biochem Pharmaceutical Corporation Information 10.5.2 Anhui Biochem Pharmaceutical Introduction and Business Overview 10.5.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered 10.5.5 Anhui Biochem Pharmaceutical Recent Development 10.6 Qilu Pharmaceutical 10.6.1 Qilu Pharmaceutical Corporation Information 10.6.2 Qilu Pharmaceutical Introduction and Business Overview 10.6.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Products Offered 10.6.5 Qilu Pharmaceutical Recent Development 10.7 Cipla 10.7.1 Cipla Corporation Information 10.7.2 Cipla Introduction and Business Overview 10.7.3 Cipla Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Cipla Tenofovir Disoproxil Fumarate Products Offered 10.7.5 Cipla Recent Development 10.8 Zydus Cadila 10.8.1 Zydus Cadila Corporation Information 10.8.2 Zydus Cadila Introduction and Business Overview 10.8.3 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Zydus Cadila Tenofovir Disoproxil Fumarate Products Offered 10.8.5 Zydus Cadila Recent Development 10.9 Dr Reddy's Laboratories 10.9.1 Dr Reddy's Laboratories Corporation Information 10.9.2 Dr Reddy's Laboratories Introduction and Business Overview 10.9.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Products Offered 10.9.5 Dr Reddy's Laboratories Recent Development 10.10 Mylan Pharmaceuticals 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Tenofovir Disoproxil Fumarate Product Category, Application and Specification 10.10.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Mylan Pharmaceuticals Recent Development 10.11 Natco Pharma 10.11.1 Natco Pharma Corporation Information 10.11.2 Natco Pharma Introduction and Business Overview 10.11.3 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Natco Pharma Tenofovir Disoproxil Fumarate Products Offered 10.11.5 Natco Pharma Recent Development 10.12 Emcure Pharmaceuticals 10.12.1 Emcure Pharmaceuticals Corporation Information 10.12.2 Emcure Pharmaceuticals Introduction and Business Overview 10.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Products Offered 10.12.5 Emcure Pharmaceuticals Recent Development 10.13 Torrent Pharmaceuticals 10.13.1 Torrent Pharmaceuticals Corporation Information 10.13.2 Torrent Pharmaceuticals Introduction and Business Overview 10.13.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Products Offered 10.13.5 Torrent Pharmaceuticals Recent Development 10.14 Wockhardt Ltd 10.14.1 Wockhardt Ltd Corporation Information 10.14.2 Wockhardt Ltd Introduction and Business Overview 10.14.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Wockhardt Ltd Tenofovir Disoproxil Fumarate Products Offered 10.14.5 Wockhardt Ltd Recent Development 10.15 Hetero Drugs 10.15.1 Hetero Drugs Corporation Information 10.15.2 Hetero Drugs Introduction and Business Overview 10.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Hetero Drugs Tenofovir Disoproxil Fumarate Products Offered 10.15.5 Hetero Drugs Recent Development 10.16 Abbott 10.16.1 Abbott Corporation Information 10.16.2 Abbott Introduction and Business Overview 10.16.3 Abbott Tenofovir Disoproxil Fumarate Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Abbott Tenofovir Disoproxil Fumarate Products Offered 10.16.5 Abbott Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Tenofovir Disoproxil Fumarate Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Tenofovir Disoproxil Fumarate Industrial Chain Analysis 11.4 Tenofovir Disoproxil Fumarate Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Tenofovir Disoproxil Fumarate Distributors 12.3 Tenofovir Disoproxil Fumarate Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 30 Pcs/Box Table 2. Major Company of 10 Pcs/Box Table 3. Global Tenofovir Disoproxil Fumarate Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (K Pcs) Table 5. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2016-2021) Table 6. Global Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US& Million) Table 7. Global Tenofovir Disoproxil Fumarate Market Share in Value by Type (2016-2021) Table 8. Global Tenofovir Disoproxil Fumarate Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Tenofovir Disoproxil Fumarate Sales by Type (2022-2027) & (K Pcs) Table 10. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2022-2027) Table 11. Global Tenofovir Disoproxil Fumarate Sales by Type (2022-2027) & (US$ Million) Table 12. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2022-2027) Table 13. Global Tenofovir Disoproxil Fumarate Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (K Pcs) Table 15. North America Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2016-2021) Table 17. Europe Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Tenofovir Disoproxil Fumarate Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Type (2016-2021) & (US$ Million) Table 24. Global Tenofovir Disoproxil Fumarate Sales by Company (2016-2021) & (K Pcs) Table 25. Global Tenofovir Disoproxil Fumarate Sales Share by Company (2016-2021) Table 26. Global Tenofovir Disoproxil Fumarate Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Tenofovir Disoproxil Fumarate Revenue Share by Company (2016-2021) Table 28. Global Market Tenofovir Disoproxil Fumarate Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Tenofovir Disoproxil Fumarate Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Tenofovir Disoproxil Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate as of 2020 Table 32. Date of Key Manufacturers Enter into Tenofovir Disoproxil Fumarate Market Table 33. Key Manufacturers Tenofovir Disoproxil Fumarate Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Tenofovir Disoproxil Fumarate Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Tenofovir Disoproxil Fumarate Sales by Region (2016-2021) & (K Pcs) Table 37. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2016-2021) Table 38. Global Tenofovir Disoproxil Fumarate Sales by Region (2016-2021) & (US$ Million) Table 39. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2016-2021) Table 40. Global Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Tenofovir Disoproxil Fumarate Sales by Region (2022-2027) & (K Pcs) Table 42. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2022-2027) Table 43. Global Tenofovir Disoproxil Fumarate Sales by Region (2022-2027) & (US$ Million) Table 44. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2022-2027) Table 45. Global Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Tenofovir Disoproxil Fumarate Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (K Pcs) Table 48. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2016-2021) Table 49. Global Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 50. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2016-2021) Table 51. Global Tenofovir Disoproxil Fumarate Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Tenofovir Disoproxil Fumarate Sales by Application (2022-2027) & (K Pcs) Table 53. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2022-2027) Table 54. Global Tenofovir Disoproxil Fumarate Sales by Application (2022-2027) & (US$ Million) Table 55. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2022-2027) Table 56. Global Tenofovir Disoproxil Fumarate Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) (K Pcs) Table 58. North America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 59. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Table 60. Europe Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) (K Pcs) Table 61. Europe Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Table 66. Latin America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Table 72. North America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (K Pcs) Table 73. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2016-2021) Table 74. North America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (US$ Million) Table 75. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2016-2021) Table 76. North America Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (K Pcs) Table 77. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2022-2027) Table 78. North America Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (US$ Million) Table 79. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2022-2027) Table 80. Europe Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2016-2021) Table 84. Europe Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Tenofovir Disoproxil Fumarate Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Tenofovir Disoproxil Fumarate Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Country (2022-2027) Table 112. Glaxo SmithKline Corporation Information Table 113. Glaxo SmithKline Introduction and Business Overview Table 114. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Table 116. Glaxo SmithKline Recent Development Table 117. Gilead PHARMACARE Corporation Information Table 118. Gilead PHARMACARE Introduction and Business Overview Table 119. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Table 121. Gilead PHARMACARE Recent Development Table 122. Chengdu Brilliant Pharmaceutical Corporation Information Table 123. Chengdu Brilliant Pharmaceutical Introduction and Business Overview Table 124. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 125. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Table 126. Chengdu Brilliant Pharmaceutical Recent Development Table 127. CHIA TAI TIANQING (CTTQ) Pharmaceutical Corporation Information Table 128. CHIA TAI TIANQING (CTTQ) Pharmaceutical Introduction and Business Overview Table 129. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 130. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Table 131. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development Table 132. Anhui Biochem Pharmaceutical Corporation Information Table 133. Anhui Biochem Pharmaceutical Introduction and Business Overview Table 134. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 135. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Table 136. Anhui Biochem Pharmaceutical Recent Development Table 137. Qilu Pharmaceutical Corporation Information Table 138. Qilu Pharmaceutical Introduction and Business Overview Table 139. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 140. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Table 141. Qilu Pharmaceutical Recent Development Table 142. Cipla Corporation Information Table 143. Cipla Introduction and Business Overview Table 144. Cipla Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 145. Cipla Tenofovir Disoproxil Fumarate Product Table 146. Cipla Recent Development Table 147. Zydus Cadila Corporation Information Table 148. Zydus Cadila Introduction and Business Overview Table 149. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 150. Zydus Cadila Tenofovir Disoproxil Fumarate Product Table 151. Zydus Cadila Recent Development Table 152. Dr Reddy's Laboratories Corporation Information Table 153. Dr Reddy's Laboratories Introduction and Business Overview Table 154. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 155. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Table 156. Dr Reddy's Laboratories Recent Development Table 157. Mylan Pharmaceuticals Corporation Information Table 158. Mylan Pharmaceuticals Introduction and Business Overview Table 159. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 160. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Table 161. Mylan Pharmaceuticals Recent Development Table 162. Natco Pharma Corporation Information Table 163. Natco Pharma Introduction and Business Overview Table 164. Natco Pharma Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 165. Natco Pharma Tenofovir Disoproxil Fumarate Product Table 166. Natco Pharma Recent Development Table 167. Emcure Pharmaceuticals Corporation Information Table 168. Emcure Pharmaceuticals Introduction and Business Overview Table 169. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 170. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Table 171. Emcure Pharmaceuticals Recent Development Table 172. Torrent Pharmaceuticals Corporation Information Table 173. Torrent Pharmaceuticals Introduction and Business Overview Table 174. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 175. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Table 176. Torrent Pharmaceuticals Recent Development Table 177. Wockhardt Ltd Corporation Information Table 178. Wockhardt Ltd Introduction and Business Overview Table 179. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 180. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Table 181. Wockhardt Ltd Recent Development Table 182. Hetero Drugs Corporation Information Table 183. Hetero Drugs Introduction and Business Overview Table 184. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 185. Hetero Drugs Tenofovir Disoproxil Fumarate Product Table 186. Hetero Drugs Recent Development Table 187. Abbott Corporation Information Table 188. Abbott Introduction and Business Overview Table 189. Abbott Tenofovir Disoproxil Fumarate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 190. Abbott Tenofovir Disoproxil Fumarate Product Table 191. Abbott Recent Development Table 192. Key Raw Materials Lists Table 193. Raw Materials Key Suppliers Lists Table 194. Tenofovir Disoproxil Fumarate Market Trends Table 195. Tenofovir Disoproxil Fumarate Market Drivers Table 196. Tenofovir Disoproxil Fumarate Market Challenges Table 197. Tenofovir Disoproxil Fumarate Market Restraints Table 198. Tenofovir Disoproxil Fumarate Distributors List Table 199. Tenofovir Disoproxil Fumarate Downstream Customers Table 200. Research Programs/Design for This Report Table 201. Key Data Information from Secondary Sources Table 202. Key Data Information from Primary Sources List of Figures Figure 1. Tenofovir Disoproxil Fumarate Product Picture Figure 2. Global Tenofovir Disoproxil Fumarate Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Tenofovir Disoproxil Fumarate Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Tenofovir Disoproxil Fumarate Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 30 Pcs/Box Figure 6. Global 30 Pcs/Box Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 10 Pcs/Box Figure 8. Global 10 Pcs/Box Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Tenofovir Disoproxil Fumarate Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2016-2021) Figure 12. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type (2022-2027) Figure 14. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2020 Figure 15. North America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2020 Figure 16. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2020 Figure 17. Europe Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2020 Figure 20. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Tenofovir Disoproxil Fumarate Revenue in 2020 Figure 26. Tenofovir Disoproxil Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of HIV-1 Infection Figure 28. Global HIV-1 Infection Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Chronic Hepatitis Figure 30. Global Chronic Hepatitis Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Other Figure 32. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Global Tenofovir Disoproxil Fumarate Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application (2016-2021) Figure 36. Global Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Tenofovir Disoproxil Fumarate Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Tenofovir Disoproxil Fumarate Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Tenofovir Disoproxil Fumarate Manufacturing Cost Structure Figure 42. Tenofovir Disoproxil Fumarate Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Glaxo SmithKline Gilead PHARMACARE Chengdu Brilliant Pharmaceutical CHIA TAI TIANQING (CTTQ) Pharmaceutical Anhui Biochem Pharmaceutical Qilu Pharmaceutical Cipla Zydus Cadila Dr Reddy's Laboratories Mylan Pharmaceuticals Natco Pharma Emcure Pharmaceuticals Torrent Pharmaceuticals Wockhardt Ltd Hetero Drugs Abbott